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cigarette smokers, using allopurinol to inhibit XO. 
Methode: Fourteen cigarette smokers with a >20 pack year history (6 males; 42±3 yrs) 
and 14 age and gender matched healthy controls (6 males; 41±3 yrs) participated in a 
double-blinded, randomized, two-phase crossover study. Subjects received either a sin- 
gle oral dose of 600 mg of allopurinol or nothing. Eodothelium-dependent responses 
were assessed by forearm blood flow responses to intra-arterial acetylcholine and brady- 
kinin. Endothelium-independent responses were tested with nitroprusside. 
Results: Baseline parameters were not significantly different between smokers and con- 
trols, except for HDL-cholesteroJ (42±2 mg/dl and 58±4 rag/hi respectively; p<0.05) and 
cerboxyhemoglobin (4.2+0.5% and 0.9_+0.2% respectively; p<0.001). After oral allopu- 
rinol, plasma oxypurinol levels reached 9.9±1.5 }~g/ml in smokers and 8.2±0.5 p.g/ml in 
controls at 7 hrs (p=0.55), and uric acid levels decreased significantly in both smokers 
(4.5+-0.6 mg/dl to 3.8_+0.6 mg/dl; p<0.05) and controls (5.0_+0.4 mg/dl to 4.1_+0.3 mg/dl; 
p<0.05). In the absence of allopurinol, forearm dilatation to acetylcholine (30 I~g/min) was 
significantly impaired in smokers (254±57%) vs. healthy controls (390±55%; p=0.04). 
AIIopurinol substantially increased responses to aeetylcholine in smokers (463±78%; 
p=0.001), which approached the levels in controls (401±80%). Bradykinin responses 
were improved similarly to acetylcholine in smokers. AIIopurinol did not improve 
responses in controls. Responses to nitroprusside were not significantly different 
between smokers (387±52%) and controls (437±36%), and were not altered by allopu- 
rinol. 
Concluelon: Xanthine oxidase contributes importantly to endothelial dysfunction in ciga- 
rette smokers. 
1128-88 Insulin Resistance Impairs Endothelial Function by 
Enhancing Oxidation of Low Density Lipoprotein in 
Healthy Young Men 
Hideo Matsui, Tomofumi Mizuno. Hiroki Kamiya, Kenji Okumura, Internal Medicine 2, 
Nagoya University School of Medicine, Nagoya, Japan. 
Background: Both insulin resistance and LDL oxidation play important roles in the 
pathogenesis of atheroscleresis. Recent studies have suggested that there is a signifi- 
cant link between these factors. In this study, we investigated the relationship between 
these factors and endothelial function in healthy young men, because endothelial dys- 
function is regarded as an early step in the development of atherosclerosis. 
Methode: Thirty-three men (aged 28.0±2.5 years), who had no history of any chronic 
diseases including diabetes mellitus, were enrolled in this study. We evaluated endothe- 
lial function estimated by flow-mediated vasodilation during reactive hyperemia, using 
high-resolution ultrasound Doppler echocardiography. We also measured plasma oxi- 
dized LDL (oxLDL) level by a sandwich ELISA method. Insulin sensitivity was estimated 
by homeostasis model assessment insulin resistance (HOMA-IR). HOMA-13-cell function 
was used to assess pancreatic insulin function. 
Results: The plasma oxLDL level was significantly correlated with the body weight 
(r=-0.436, P<0.05), body mass index (r=0.459, P<0.01), LDL-cholestarol (r=-0.386, 
P<0.05), and HOMA-E~-cell function (r=-0.339, P<0.05). Furthermore, HOMA-B-cell func- 
tion was significantly correlated with endothelium-dependent flow-mediated vasodilation 
(r=--0.376, P<0.05). When we divided these subjects into two subgroups according to 
HOMA-IR level (insulin-resistant group with a HOMA-IRP_2.5 and insulin-sensitive group 
with a HOMA-IR<2.5), the plasma oxLDL level and HOMA-I3-cell function were signifi- 
cantly correlated with flow-mediated vasodilation (r=--0.568 and -0.521, P<0.05; respec- 
tively) in insulin-resistant group. In contrast, insulin-sensitive group showed no significant 
relationship between these parameters and flow-mediated vasodilation. A stepwise multi- 
ple regression analysis in insulin-resistant group showed that the plasma oxLDL and 
insulin levels were determinants of flow-mediated vasodilation (/:12=0.503). 
Conclusions: These results suggest the possibility that insulin resistance enhances oxi- 
dation of circulating LDL particles and thus impairs endothelial function even in healthy 
young men. 
1128-89 Immunizat ion  With a Novel Human Apo B100 Related 
PepUde Reduces Atheroscleroais and Inflammation in 
Apo E Null Mice 
Odette S. Raves, Kuang-Yuh Chyu, Juliana Yano, Xioaning Zhao, Bojan Cercek, Sanjay 
Kaul, Jan Nilsson, Prediman K. Shah, Cedars-Sinai Medical Center, Los Angeles, 
California, Lund Universi~ Malmo, Sweden. 
Background: Immunization with homologous LDL reduces atherosclerosis in animals. To 
develop a clinically testable strategy, we sought to design and test human apoB100 
related peptides as immunogens. 
Method: A polypeptide library of 20 amino acid peptides covering the human apoB 
sequence was screened. Two peptides were subsequently tested using patient and nor- 
mal sere, and identified as potential immunogens. Six-week old apoE null mice were then 
immunized with 33 pg of P1 (n=10) or P2 (n=l 0) with Alum as adjuvant, followed 3 weeks 
later by a booster. Controls received Alum alone (N=9). Mice were fed high cholesterol 
chow from 11 weeks of age until sacrifice at 25 weeks. Oil red-O stain of en-face pre- 
pared aorta was used to assess extent of atherosclarosis. Macrophage immunoreactivity 
and trichrome staining were used to assess and compare plaque composition in the aor- 
tic sinus. 
Result: 
Table 1: Aortic plaque size and aortic sinus lesion composition. 
ABSTRACTS - Hypertension, Vascular Disease, and Prevention 
Group Aortic Plaque Area Macrophage Collagen 
Alum 20+5% 6.6+-2.3% 32.3+_5.3% 
P1 17_+4% 13.6+_5.3%* 35.6+8.5% 
P2 6+2%*1- 1.3:L-0.6%*1- 39.9+-7.7%* 
*p<0.05 vs. Alum; 1-p<0.05 vs. P1 
Mean plasma cholesterol levels were greater than 1000 mg/dl in all groups except P1 
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group (715 mg/dl). 
Conclusion: Immunization with specific human apoB100 related peptide P2 markedly 
reduced aortic atherosclerosis, reduced inflammation, and altered plaque composition in 
apo E null mice despite severe hypercholesterolemia raising the possibility of future clini- 
cal testing. 
1128-90 Se lect ive  Express ion  o f  Tenasc in  in the Coronary Artery  
and Its High Affinity Interaction With LDL May Account 
fo r  Lipid Retention Capacity of Coronary Vessels and 
Their Susceptibility to Atherosclerosis 
Behrooz G. Sharifi. Minghui Qin, Theresa Pan, Prediman K. Shah, Cedars-Sinai Med. 
Ct~, Los Angeles, California. 
Background: Several studies have shown that internal mammary artery (IMA) in its native 
position as well as when grafted into coronary circulation is resistant to atherosclerosis 
even in patients with extensive atherosclerosis elsewhere. To understand the molecular 
basis for the athero-permissive nature of the coronary artery and athero-protactive prop- 
erties of mammary artery. 
Methods: We have used porcine coronary and mammary arteries, and suppression sub- 
tractive hybridization (SSH) to generate profile of artery-specific gene expression. From a 
3000 clones SSH-cDNA repertoire, we have screened the libraries by dot blot array and 
sequenced 2000 promising artery-specific lones. Northern blot and in-sifu hybridization 
confirmed the differential gene expression pattern identified by the array. Cluster analysis 
of the sequences revealed that extracellular matrix genes that are involved in lipid reten- 
tion and metabolism are predominantly expressed in the coronary artery. We hypothe- 
sized that, unlike IMA, the extracellular matrix of the coronary artery retains lipids. 
Therefore, we examined the interaction between tenascin, a coronary-specific gene, and 
LDL and minimally oxidized LDL (mo-LDL). 
Results: Both LDL and mo-LDL exhibited concentration-dependent sa urable binding to 
tenascin with similar apparent Kd values of 4.2 ± 2.6 and 5.1 ± 1.2 nM, respectively. The 
Bmax for ox-LDL was about 55% less than that for LDL, 28.4 ± 4.9 and 65.8 ± 12.6 fmol, 
respectively. Additional experiments showed that at physiologic concentrations, Ca2+ 
and Mg2 increase LDL binding to Tenascin 2.3- and 1.9-fold respectively. 
Conclusion: Taken together with the preferential expression of other lipid binding proteins 
in the coronary artery, the expression of tenascin and its high affinity binding to LDL 
raises a possibility that unlike mammary artery, coronary arteries have an intrinsic capac- 
ity to retain lipids. This may partly explain the athero-permissive nature of coronaries. 
1128-91 Inhibition of Atheroaclerosis in Apo E Null Mice by 
Immunization With Native and MDA-Modified Apo B 
Peptlde Sequences 
Gunilla Nordin Freddkson. Marie Lindholm, Ingrid S~derberg, Paul Dimayuga, Jan 
Nilsson, Department of Medicine, Maim6, Sweden. 
LDL oxidation is believed to have an important role in the development of atherosciero- 
sis. Oxidized LDL has been shown to activate antibody-mediated immune responses. 
Experiments in which animals have been immunized with oxidized LDL suggest that 
these immune responses inhibit atherosclerosis. Epitopes in oxidized LDL that induce 
antibody formation in man was identified by ELISA using a library of native and MDA- 
modified polypeptides covering the complete apo B sequence. The abUity of these 
epitopes to induce athero-protective immune responses was then analysed in apo E null 
mice. Mice were immunized at 6 and 9 weeks of age with 100 p.g of (A) MDA-modifiad 
peptides against which high IgG levels were detected in CHD patients, (B) native pep- 
tides against which high IgG and IgM levels were detected in healthy controls and (C) 
MDA-modifled peptides against which high IgG levels were detected in healthy controls, 
using Alum as adjuvant. The mice were given a high cholesterol diet from 10 weeks of 
age and sacrificed at 25 weeks. Immunization with peptides B and C resulted in a signifi- 
cant inhibition of atheresclerosis as assessed by Oil Red O staining of flat prep aortas 
(0.102t-0.055% and 0.124+-0,086% lesion area) as compared to controls given adjuvant 
alone 0.287_+0.071%; p<0.0001), immunization with peptides A did not influence lesion 
formation (0.338+_0.079%). Cholesterol levels were not affected by immunization with any 
of the peptides. These studies have identified peptide sequences in oxidized LDL that 
induce immune responses that inhibits atheresclerosis and suggest the possibility of 
developing an immunization therapy for CHD. 
1128-92 LOX-1 Mediates  Ox id i zed  LDL-Induced the Expression 
of Matrix Metalloproteinases in Human Coronary Artery 
Endothelial Cel ls  
Davuan Li. Ling Liu, Hongjiang Chen, Tatsuya Sawamure, Francesco Romeo, Nelly 
Kazzaz, Jorge F. Saucedo, Jawahar L. Mehta, University of Arkansas for Medical 
Sciences, Little Rock, Arkansas, Central Arkansas Veterans Healthcere System, Little 
Rock, Arkansas. 
Background and objectives: Increasing evidence indicates that oxidized low-density lipo- 
protein (ox-LDL) may increase plaque instability. Studies have demonstrated that plasma 
ox-LDL levels and ox-LDL receptor LOX-1 expression are significantly increased in ath- 
erosclerotie plaques. This study was designed to observe the role of LOX-1 in modulation 
of MMPs and the tissue inhibitors of MMPs (TIMPs) and related cellular mechanism(s) in 
human coronary artery endothelial cells (HCAECs). 
Methods and results: HCAECs were cultured and incubated with ox-LDL (10 to 50 mg/ 
ml) for 6 to 24 hours. Ox-LDL increased the expression of mRNA (determined by semi- 
quantitative RT-PCR) and protein (determined by Western blot) of MMP1 (interstitial col- 
lagenase) and MMP3 (stromeolysin 1) in a concentration- and time-dependent fashion. 
Ox-LDL also moderately increased the expression of TIMP1 and TIMP2 (mRNA and pro- 
tein). Native-LDL had no effect on the expression of MMPs and TIMP2. These effects of 
ox-LDL was mediated by its endothelial receptor LOX-1 since pretreatment of HCAECs 
